NCT02709564View on ClinicalTrials.gov

Sublingual Misoprostol in Decreasing Blood Loss Prior to Myomectomy

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

December 31, 2019

Study Completion Date

February 29, 2020

Conditions
Blood Loss in Myomectomy
Interventions
DRUG

Misoprostol 400 sublingual

patients will take 2 tablets of sublingual misoprostol 400 microgram 3 hours and 1 hour before the surgery

DRUG

placebo 400 sublingual

patients will take 2 tablets of sublingual placebo 400 microgram 1 hour before the surgery

Trial Locations (1)

002

Ahmed Abbas, Assiut

All Listed Sponsors
lead

Assiut University

OTHER

NCT02709564 - Sublingual Misoprostol in Decreasing Blood Loss Prior to Myomectomy | Biotech Hunter | Biotech Hunter